What We Offer
Within the life science industry successful product research is the key to sustaining ameaningful product pipeline. Amid increasing regulation surrounding product safety, thenumber of registered clinical trials has grown exponentially with increasing territorialdiversity. With insurance requirements incredibly nationalistic it is critical to ally withunderwriters who understand the nuances of individual countries.
- Annually renewable or full duration contracts
- Off-the-shelf or bespoke insurance policies
- Access to licensed paper in over 100 countries
- Multi-territory programmes
- Master policy contracts including Difference in Conditions / Difference in Limits provisions
- Run-off cover extensions possible
- Packages with other classes such as General Liability and Medical Malpractice
What We Target
- Phase I, II, III and IV trials
- Bio-equivalence and investigator-led studies
- Sponsored trials of drug, medical device, nutraceutical and biotechnology companies
- Contingent exposures of hospitals, charities and educational establishments
- Biotechnology associations
Why We're Different
The best clinical trials insurance service, made possible by:
- Lloyd’s license allowing extensive centralised policy issuanc
- In-house expertise allowing rapid quotation turnaround times
- Partnership with the leading operators in this class
- Trials of up to 10 years in study duration covered (with discovery / sunset periods in addition)
- Fully compliant policies in native languages where applicable
- Global knowledge of trials – we keep up to date with the frequent changes to regulatory and ethics committee policy requirements and listen to their feedback
- Wide US appetite with ability to consider US trials by US parented companies
- Competitive pricing that is sustainable and recognises the breadth of risk in this class
The Team
Daniel Starmer
Director of Life Science Liability
Anthony Wright
Head of Commercial Liability
James Banks
Director of Healthcare
